Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G, Dawn B: The late phase of preconditioning and its natural clinical application–gene therapy. Heart Fail Rev. 2007, 12: 189-199. 10.1007/s10741-007-9031-4.
Article
CAS
PubMed
Google Scholar
Ferdinandy P, Schulz R, Baxter GF: Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning. Pharmacol Rev. 2007, 59: 418-458. 10.1124/pr.107.06002.
Article
CAS
PubMed
Google Scholar
Miki T, Itoh T, Sunaga D, Miura T: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol. 2012, 11: 67-10.1186/1475-2840-11-67.
Article
PubMed Central
PubMed
Google Scholar
Vaage J, Valen G: Preconditioning and cardiac surgery. Ann Thorac Surg. 2003, 75: S709-714. 10.1016/S0003-4975(02)04696-9.
Article
PubMed
Google Scholar
Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005, 54: 2360-2364. 10.2337/diabetes.54.8.2360.
Article
CAS
PubMed
Google Scholar
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.
Article
PubMed
Google Scholar
Dohi T, Miyauchi K, Kasai T, Kajimoto K, Kubota N, Tamura H, Yokoyama T, Kojima T, Yokoyama K, Kurata T, Daida H: Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J. 2009, 73: 1454-1458. 10.1253/circj.CJ-08-1122.
Article
PubMed
Google Scholar
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.
Article
CAS
PubMed
Google Scholar
ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572.
Article
Google Scholar
Van der Mieren G, Van den Bergh A, Nevelsteen I, Vanderper A, Flameng W, Herijgers P: Hypoxic preconditioning preserves cardiac contractility and reduces infarct size in vivo. The Open Surgery Journal. 2008, 2: 24-29. 10.2174/1874300500802010024.
Article
Google Scholar
Ebel D, Müllenheim J, Frässdorf J, Heinen A, Huhn R, Bohlen T, Ferrari J, Südkamp H, Preckel B, Schlack W, Thämer V: Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo. Pflugers Arch. 2003, 446: 175-182.
CAS
PubMed
Google Scholar
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, American Heart Association; American Diabetes Association: Primary prevention of cardiovascular disease in people with diabetes mellitus. A Scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007, 115: 114-126.
Article
PubMed
Google Scholar
Abete P, Testa G, Galizia G, Mazzella F, Della Morte D, de Santis D, Calabrese C, Cacciatore F, Gargiulo G, Ferrara N, Rengo G, Sica V, Napoli C, Rengo F: Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart. Exp Gerontol. 2005, 40: 43-50. 10.1016/j.exger.2004.10.005.
Article
CAS
PubMed
Google Scholar
Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P: Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation. 2004, 110: 3259-3269. 10.1161/01.CIR.0000147614.85888.7A.
Article
CAS
PubMed
Google Scholar
Miki T, Miura T, Ura N, Ogawa T, Suzuki K, Shimamoto K, Limura O: Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. J Am Coll Cardiol. 1996, 28: 1616-1622. 10.1016/S0735-1097(96)00371-3.
Article
CAS
PubMed
Google Scholar
Nozawa Y, Miura T, Tsuchida A, Kita H, Fukuma T, Shimamoto K: Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning. Cardiovac Drugs Ther. 1999, 13: 151-157. 10.1023/A:1007744428819.
Article
CAS
Google Scholar
Jaberansari MT, Baxter GF, Muller CA, Latouf SE, Röth E, Opie LH, Yellon DM: Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. J Am Coll Cardiol. 2001, 37: 1996-2001. 10.1016/S0735-1097(01)01232-3.
Article
CAS
PubMed
Google Scholar
Marktanner R, Nacke P, Feindt P, Hohlfeld T, Schipke JD, Gams E: Delayed preconditioning via Angiotensin-converting enzyme inhibition: pros and cons from an experimental study. Clin Exp Pharmacol Physiol. 2006, 33: 787-792. 10.1111/j.1440-1681.2006.04439.x.
Article
CAS
PubMed
Google Scholar
Velasquez MT, Bhathena SJ, Striffler JS, Thibault N, Scalbert E: Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. Metabolism. 1998, 47: 7-11.
Article
CAS
PubMed
Google Scholar
Van den Bergh A, Vanderper A, Vangheluwe P, Desjardins F, Nevelsteen I, Verreth W, Wuytack F, Holvoet P, Flameng W, Balligand JL, Herijgers P: Dyslipidemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res. 2008, 77: 371-379.
Article
CAS
PubMed
Google Scholar
Van der Mieren G, Nevelsteen I, Vanderper A, Oosterlinck W, Flameng W, Herijgers P: Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury. Cardiovasc Diabetol. 2012, 11: 89-10.1186/1475-2840-11-89.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wichi R, Farah V, Chen Y, Irigoyen MC, Morris M: Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R1184-1189.
Article
CAS
PubMed
Google Scholar
Van den Bergh A, Flameng W, Herijgers P: Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state. Pflugers Arch. 2008, 455: 987-994. 10.1007/s00424-007-0362-8.
Article
CAS
PubMed
Google Scholar
Poornima IG, Parikh P, Shannon RP: Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 2006, 98: 596-605. 10.1161/01.RES.0000207406.94146.c2.
Article
CAS
PubMed
Google Scholar
Hausenloy DJ, Yellon DM: Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007, 12: 217-234. 10.1007/s10741-007-9026-1.
Article
CAS
PubMed
Google Scholar
Guo Y, Sanganalmath SK, Wu W, Zhu X, Huang Y, Tan W, Ildstad ST, Li Q, Bolli R: Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2012, 107: 1-8.
Google Scholar
Natali A, Ferrannini E: Endothelial dysfunction in type 2 diabetes. Diabetologia. 2012, 55: 1559-1563. 10.1007/s00125-011-2445-5.
Article
CAS
PubMed
Google Scholar
Marfella R, Di Filippo C, Esposito K, Nappo F, Piegari E, Cuzzocrea S, Berrino L, Rossi F, Giugliano D, D'Amico M: Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes. 2004, 53: 454-462. 10.2337/diabetes.53.2.454.
Article
CAS
PubMed
Google Scholar
Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, Di Marino MP, Baldi A, Cuzzocrea S, Di Filippo C, Barboso G, Baldi F, Rossi F, D'Amico M, Giugliano D: Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes. 2004, 53: 2383-2391. 10.2337/diabetes.53.9.2383.
Article
CAS
PubMed
Google Scholar
Das DK, Maulik N: Cardiac genomic response following preconditioning stimulus. Cardiovasc Res. 2006, 70: 254-263. 10.1016/j.cardiores.2006.02.023.
Article
CAS
PubMed
Google Scholar
Halestrap AP, Clarke SJ, Javadov A: Mitochondrial permeability transition pore opening during myocardial reperfusion- a target for cardioprotection. Cardiovasc Res. 2004, 61: 372-385. 10.1016/S0008-6363(03)00533-9.
Article
CAS
PubMed
Google Scholar
Abete P, Cacciatore F, Testa G, Della-Morte D, Galizia G, de Santis D, Calabrese C, Cioppa A, Ferrara N, Rengo F: Ischemic preconditioning in the aging heart: from bench to bedside. Ageing Res Rev. 2010, 9: 153-162. 10.1016/j.arr.2009.07.001.
Article
PubMed
Google Scholar
Bachetti T, Comini L, Pasini E, Cargnoni A, Curello S, Ferrari R: Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats. J Mol Cell Cardiol. 2001, 33: 395-403. 10.1006/jmcc.2000.1311.
Article
CAS
PubMed
Google Scholar
Sohal RS, Ku HH, Agarwal S, Forster MJ, Lal H: Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev. 1994, 74: 121-133. 10.1016/0047-6374(94)90104-X.
Article
CAS
PubMed
Google Scholar